Is platinum the new gold? Re-evaluating platinum's enduring role and future potential in the era of novel ovarian cancer therapies
Authors:
- Alvaro Lopez-SanchezAlvaro Lopez-Sanchez
- Giulia AdrianiGAGiulia Adriani
- Giorgia PastorinGPGiorgia Pastorin
Open Access
- 6 May 2026
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 395, 114996
Abstract
No abstract availableKeywords
Funding Information
- Sorbonne Université
- Ministry of Education - Singapore
- Ligue Contre le Cancer
- National Additive Manufacturing Innovation Cluster
- National University of Singapore
This publication has 230 references indexed in Scilit:
- Ovarian CancerJAMA, 2025
- Fluorescence‐Guided Spatial Drug Screening in 3D Colorectal Cancer SpheroidsAdvanced Healthcare Materials, 2024
- Fighting against Drug‐Resistant Tumors using a Dual‐Responsive Pt(IV)/Ru(II) Bimetallic PolymerAdvanced Materials, 2020
- Molecularly Imprinted Polymer Nanoparticles: An Emerging Versatile Platform for Cancer TherapyAngewandte Chemie International Edition, 2020
- Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced NephrotoxicityAngewandte Chemie International Edition, 2019
- Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate CancerJAMA Oncology, 2018
- Metal–Organic Framework (MOF)‐Based Drug/Cargo Delivery and Cancer TherapyAdvanced Materials, 2017
- Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of MesotheliomaChemMedChem, 2011
- Studies of Glutathione Transferase P1‐1 Bound to a Platinum(IV)‐Based Anticancer Compound Reveal the Molecular Basis of Its ActivationChemistry – A European Journal, 2011
- Multidrug resistance in ovarian cancerCancer, 1987